Viviane Yargeau

Prof. Viviane Yargeau

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2014 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
HEHanno Erythropel
Hanno Erythropel
Milan MaricMilan Maric
Milan Maric
JNJim Nicell
Jim Nicell
RLRichard L. Leask
Richard L. Leask
VYViviane Yargeau
Viviane Yargeau

1 April 2020 in Water Research
Verified
Journal Article
Closed access
CHChee-Hun Han
Chee-Hun Han
HPHee-Deung Park
Hee-Deung Park
SKSong-Bae Kim
Song-Bae Kim
VYViviane Yargeau
Viviane Yargeau
Jae-Woo ChoiJae-Woo Choi
Jae-Woo Choi
JPJeong-Ann Park
Jeong-Ann Park

23 October 2019 in Addiction
Verified
Journal Article
Open access
PDF file
IGIria González-Mariño
Iria González-Mariño
JBJose Antonio Baz‐Lomba
Jose Antonio Baz‐Lomba
Nikiforos AlygizakisNikiforos Alygizakis
Nikiforos Alygizakis
MAMaria Jesús Andrés‐Costa
Maria Jesús Andrés‐Costa
RBRichard Bade
Richard Bade
COChristoph Ort
Christoph Ort
Background and aims: Wastewater‐based epidemiology is an additional indicator of drug use that is gaining reliability to complement the current established panel of indicators. The aims of this study were to: (i) assess spatial and temporal trends of population‐normalized mass loads of benzoylecgonine, amphetamine, methamphetamine and 3,4‐methylenedioxymethamphetamine (MDMA) in raw wastewater over 7 years (2011–17); (ii) address overall drug use by estimating the average number of combined doses consumed per day in each city; and (iii) compare these with existing prevalence and seizure data.Design: Analysis of daily raw wastewater composite samples collected over 1 week per year from 2011 to 2017.Setting and Participants: Catchment areas of 143 wastewater treatment plants in 120 cities in 37 countries.Measurements: Parent substances (amphetamine, methamphetamine and MDMA) and the metabolites of cocaine (benzoylecgonine) and of Δ9‐tetrahydrocannabinol (11‐nor‐9‐carboxy‐Δ9‐tetrahydrocannabinol) were measured in wastewater using liquid chromatography–tandem mass spectrometry. Daily mass loads (mg/day) were normalized to catchment population (mg/1000 people/day) and converted to the number of combined doses consumed per day. Spatial differences were assessed world‐wide, and temporal trends were discerned at European level by comparing 2011–13 drug loads versus 2014–17 loads.Findings: Benzoylecgonine was the stimulant metabolite detected at higher loads in southern and western Europe, and amphetamine, MDMA and methamphetamine in East and North–Central Europe. In other continents, methamphetamine showed the highest levels in the United States and Australia and benzoylecgonine in South America. During the reporting period, benzoylecgonine loads increased in general across Europe, amphetamine and methamphetamine levels fluctuated and MDMA underwent an intermittent upsurge.Conclusions: The analysis of wastewater to quantify drug loads provides near real‐time drug use estimates that globally correspond to prevalence and seizure data.

16 April 2011 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
SLSimone Larcher
Simone Larcher
VYViviane Yargeau
Viviane Yargeau

17 August 2012 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
SLSimone Larcher
Simone Larcher
VYViviane Yargeau
Viviane Yargeau

1 July 2014 in Science of The Total Environment
Verified
Journal Article
Closed access
VYViviane Yargeau
Viviane Yargeau
BTBryanne Taylor
Bryanne Taylor
HLHongxia Li
Hongxia Li
ARAngela Rodayan
Angela Rodayan
CMChris D. Metcalfe
Chris D. Metcalfe